![Hamzeh Abdul-Hadi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hamzeh Abdul-Hadi
Private Equity Investor chez Debiopharm Innovation Fund /Management/
Profil
Mr. Hamzeh Abdul-Hadi is an Associate at Hikma Ventures Ltd.
and a Research Analyst at Capital Investment & Brokerage Co.
Postes actifs de Hamzeh Abdul-Hadi
Sociétés | Poste | Début |
---|---|---|
Debiopharm Innovation Fund /Management/
![]() Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland. | Private Equity Investor | 01/07/2022 |
Anciens postes connus de Hamzeh Abdul-Hadi
Sociétés | Poste | Fin |
---|---|---|
Capital Investment & Brokerage Co.
![]() Capital Investment & Brokerage Co. Investment Banks/BrokersFinance Capital Investment & Brokerage Co. is a broker/dealer headquartered in Amman, Jordan. It was founded in 19995 and is a subsidiary of Capital Bank of Jordan (ASE: EXFB). The firm provides a range of brokerage services to various clients. | Analyst-Equity | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Capital Investment & Brokerage Co.
![]() Capital Investment & Brokerage Co. Investment Banks/BrokersFinance Capital Investment & Brokerage Co. is a broker/dealer headquartered in Amman, Jordan. It was founded in 19995 and is a subsidiary of Capital Bank of Jordan (ASE: EXFB). The firm provides a range of brokerage services to various clients. | Finance |
Debiopharm Innovation Fund /Management/
![]() Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland. | Finance |